ProShare Advisors
IGMS

ProShare Advisors’s IGM Biosciences IGMS Stock Holding History

ProShare Advisors’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,510
Closed -$428K – 2342
2021
Q3 		$428K Sell
6,510
-180
-3% -$13.8K ﹤0.01% 1302
2021
Q2 		$557K Buy
6,690
+1,167
+21% +$86.5K ﹤0.01% 1454
2021
Q1 		$424K Buy
5,523
+205
+4% +$18.7K ﹤0.01% 1553
2020
Q4 		$470K Buy
+5,318
New +$374K ﹤0.01% 1318

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ProShare Advisors's IGMS Position: Q4 2021 in Review

ProShare Advisors sold out of IGM Biosciences (IGMS) in Q4 2021, closing a stake of 6,510 shares — an estimated $428K sold.

ProShare Advisors first reported a position in IGMS in Q4 2020 and held it in 4 quarters. The position peaked at $557K in Q2 2021. 87 funds tracked by Wall St. Rank hold IGMS as of Q4 2021.

  • ProShare Advisors reported no remaining IGM Biosciences position as of Q4 2021 after selling out during the quarter.
  • ProShare Advisors sold 6,510 IGM Biosciences shares in Q4 2021, an estimated $428K.
  • ProShare Advisors first reported a position in IGM Biosciences in Q4 2020 and held it in 4 quarters.
  • ProShare Advisors's IGM Biosciences position peaked at $557K in Q2 2021.
  • 87 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2021.

Based on ProShare Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.